| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-60 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0629
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-063 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
| filingDate |
2017-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101960655-B1 |
| titleOfInvention |
Methods for direct convertion of human urine cells into keratinocyte stem cells and methods for manufacturing composition for promoting skin wound healing using induced keratinocyte stem cells |
| abstract |
The present invention relates to a method for inducing the differentiation of keratinocyte stem cells from urine cells by introducing dedifferentiation factors Bmi1 and dNP63a, and a composition for promoting skin regeneration using the induced regenerated keratinocyte stem cell conditioned medium as an active ingredient will be. |
| priorityDate |
2017-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |